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Background: Due to the potential of human papillomavirus (HPV) vaccination for decreasing cervical cancer rates
in Mainland China, where some of the highest incidences in the world have been reported, our study aimed to
assess HPV and HPV vaccine knowledge, and to evaluate the effect of a brief educational intervention on HPV
knowledge and vaccine acceptability in Chinese undergraduate students and employed women.
Methods: This multi-center, cross-sectional study was conducted across five representative cities of the five main
geographical regions of Mainland China. Participants were selected from one comprehensive university and three
to four companies in each city for a total of six comprehensive universities and 16 companies. A 62-item
questionnaire on HPV knowledge and HPV vaccine acceptability was administered to participants before and after
an educational intervention. The intervention consisted of an informative group lecture.
Results: A total of 1146 employed women and 557 female undergraduate students were surveyed between
August and November 2011. Baseline HPV knowledge was low among both groups— 320/1146 (28%) of employed
women and 66/557 (12%) of students had heard of HPV, while only 237/1146 (21%) of employed women and 40/
557 (7.2%) of students knew that HPV is related to cervical cancer. After educational instruction, 947/1061 (89%) of
employed women and 193/325 (59%) of students knew the relationship between HPV and cervical cancer (χ2 =
1041.8, p < 0.001 and χ2 = 278.5, p < 0.001, respectively). Post-intervention, vaccine acceptability increased from
881/1146 (77%) to 953/1061 (90%), (p = <0.001) in employed women and 405/557 (73%) in students to 266/325
(82%), (p < 0.001). Women in both groups cited concerns about the HPV vaccine’s safety, efficacy, and limited use
to date as reasons for being unwilling to receive vaccination. 502/1146 (44%) of women were willing to vaccinate
their children at baseline, which increased to 857/1061 (81%) post-intervention, p < 0.001.
Conclusions: Incorporation of our lecture-based education initiative into a government-sponsored or school-based
program may improve HPV-related knowledge and HPV vaccine acceptability. Further studies are needed to
evaluate and standardize HPV education programs in China.
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Despite recent strides made in HPV vaccination and
education, over half a million women worldwide develop
cervical cancer each year. Over 85% of these cases occur
in developing countries such as China due to the lack of
effective screening and prevention programs [1,2]. The
incidence of cervical cancer in Mainland China increased
from 5.14 persons per 100,000 in 2004 to 6.87 persons
per 100,000 in 2008 [3-5]. Persistent infection with high-
risk human papillomavirus (hrHPV) subtypes has been
established as the primary cause of squamous cell cervical
cancer [6]. In China, HPV 16 and 18 are implicated in the
etiology of over 84.5% of cervical malignancies [7,8].
Both the bivalent and quadrivalent HPV vaccines have
been demonstrated to effectively prevent the development
of high-grade cervical neoplasias, particularly when given
to girls before they become sexually active [9-12]. The
prophylactic HPV vaccines currently undergoing clinical
trials in Mainland China hold potential to significantly
decrease cervical cancer mortality rates in the future. Prior
to the licensure and widespread use of these vaccines,
HPV education plays a crucial role in vaccine acceptability
in the general population [13]. Studies have demonstrated
that mothers with higher HPV knowledge have increased
vaccine uptake and express greater willingness to vaccin-
ate their children [14,15].
Previous studies on knowledge and attitudes about HPV
among different groups of Chinese women have revealed
high vaccine acceptability but low levels of knowledge
about HPV and cervical cancer [16]. A pilot study by
Kwan et al. (2008) demonstrated only 38% of women in
Hong Kong had heard of HPV [17]. Zhao et al. (2012)
confirmed that knowledge about HPV was similarly low in
Mainland China, with 34% of urban women, 16% of rural
women, and 44% of government officials having heard of
HPV. Of concern, less than 20% of healthcare workers
correctly identified the ideal time for HPV vaccination as
prior to sexual debut [18]. These data suggest a strong
need for HPV and HPV vaccine education in the general
female population in Mainland China.
In recent years, there has been a proliferation of
HPV education studies internationally. Educational in-
struction on HPV-related diseases has been demon-
strated to effectively raise HPV knowledge and vaccine
acceptability in America [19,20], Sweden [21], Korea
[22], and Turkey [23,24]. Although previous studies
have assessed the effect of education instruction on
HPV-related knowledge in Hong Kong [25-27], the
differing socioeconomic factors and the availability of
the HPV vaccine in Hong Kong make the findings less
applicable to Mainland China. In our present study, we
report the results of a multi-center study examining
the effect of a brief educational intervention on HPV
vaccine-related knowledge and attitudes among employedwomen and undergraduate female students in Mainland
China.
Methods
Participants and recruitment
This was a multi-center, cross-sectional study across the
five main geographical regions of Mainland China. One
large, economically developed city was selected from
each of the five geographic regions of China (northern
Beijing, eastern Hangzhou, central Changsha, southwest-
ern Chengdu, and southern Guangzhou). Participants
were then selected from one comprehensive university
and three to four companies in each city for a total of six
comprehensive universities and 16 companies. Participants
were recruited by flyers and poster announcements in lec-
ture halls, student centers, and the employment units at
local companies.
Informed consent
Prior to enrollment, all participants were fully informed
about the objectives of the study, benefits and risks associ-
ated with participation, and assured of the confidentiality
of the information they provide. After informed consent
was obtained, a 62-item, multiple-choice questionnaire
was administered to participants. The questionnaire
was adapted from those based on expert opinions and
used in previous studies among different populations
across Mainland China [16,18]. The same questionnaire
was administered again following the educational inter-
vention to assess differences in HPV knowledge and
vaccine attitudes. This study was approved by the Insti-
tutional Review Board of the Cancer Institute, Chinese
Academy of Medical Sciences (CICAMS).
Educational intervention
The educational intervention consisted of a one-hour
group lecture followed by the same questionnaire as the
one given after informed consent. Questions were written
in Mandarin Chinese in simple terms appropriate for the
level of education of the participants as previously vali-
dated [16,18]. Participants were encouraged to complete
the questionnaire independently and trained staff mem-
bers stood by to answer any questions participants had.
The study flowchart is shown in Figure 1.
Statistical analysis
The data manager organized the database using EpiData
3.1. To ensure accuracy, two different research members
entered data separately. Data analysis was performed using
SPSS software version 18.0. Chi-square or F-test analysis
was performed on the demographic characteristics of
participants such as age, occupation, and geographic
region. Multivariate analysis of all descriptive factors
was performed to compare pre- and post-interventional
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Figure 1 Study flowchart.
Chang et al. BMC Public Health 2013, 13:916 Page 3 of 8
http://www.biomedcentral.com/1471-2458/13/916HPV and vaccine knowledge. Logistic regression was
performed to analyze the association between potential
predictor variables and willingness to receive vaccin-
ation. Odds ratios (ORs) with 95% confidence intervals
(CIs) were calculated based on Wald Chi-square statis-
tics. Statistical significance was set at p < 0.05.
Results
From August to November of 2011,1146 employed women
and 557 female undergraduate students were surveyed.
After excluding incomplete questionnaires, 1061 and 325
surveys were included in the post-interventional analysis,
respectively.
Demographics
Table 1 shows demographic and medical information about
the participants. Average age of 37.0 ± 10 for employed
women and 20.4 ± 1.2 for undergraduate students. Among
the undergraduate students, 385/557 (70%) were under-
classmen and 163/557 (30%) were upperclassmen.
Pre-intervention HPV- related knowledge
At baseline, 1089/1146 (95%) of employed women and
440/557 (79%) of female undergraduate students had
heard of cervical cancer. However, HPV knowledge was
low in both groups, with only 321/1146 (28%) of employed
women and 66/557 (12%) female students having heard of
HPV. 237/1146 (21%) of employed women and 40/557
(7.2%) of students knew that HPV infection causes cervicalcancer, but only 51/1146 (4.5%) and 18/557 (3.2%) knew
the association between HPV and genital warts, respect-
ively. Similarly, only 147/1146 (13%) employed women
and 62/557 (11%) students had heard of the HPV vaccine.
212/1146 (18%) and 69/557 (12%) knew that the vaccine
could prevent cervical cancer, respectively. 103/1146 (9%)
of employed women were not concerned about developing
cervical cancer. Knowledge of HPV and cervical cancer
did not differ significantly between women from different
geographical regions (p > 0.05). Baseline HPV knowledge
is summarized in Figure 2.
Post-interventional HPV-related knowledge
After a brief educational narrative about HPV and cervical
cancer, HPV-related knowledge increased significantly.
Comparison of pre- and post-interventional HPV know-
ledge is shown in Figure 3. Post-intervention, 947/1061
(89%) of employed women knew that HPV infection
caused cervical cancer from 237/1146 (21%) at baseline, a
4.2 fold increase from baseline (χ2 = 1041.8, p < 0.001).
Among undergraduate students, knowledge of this causal
relationship increased over seven-fold from 40/557 (7.2%)
to 193/325 (59%), (χ2 = 278.5, p < 0.001).
Post-interventional knowledge about HPV-related
diseases and risk factors for HPV infection also in-
creased significantly. In particular, correct identification
of the ideal time for HPV vaccination as prior to sexual
debut increased significantly from 246/1146 (21%) to
725/1061 (68%) in employed women and 205/557 (37%)
Table 1 Characteristics of employed women and female
undergraduate students
Characteristics Employed
women (n, %)
Undergraduate
students (n, %)
Total participants (N) 1146 557
Age (years, mean ± SD) 37.0 ± 10.0 20.4 ± 1.2
Age at menarche (years, mean ± SD) 13.6 ± 13.0 13.1 ± 1.3
Education level
< High school 408 (35.6) -
≥ Some college 703 (61.3) -
University grade*
Lower classmen - 385 (69.1)
Upper classmen - 163 (29.3)
Number of lifetime sexual partners
1 668 (58.3) -
≥2 87 (7.6) -
Contraceptive method
None 520 (45.3) -
Condoms (barrier method) 438 (38.2) -
Undergoes regular gynecologic exam
Yes 868 (75.7) -
No 178 (15.5) -
History of genital tract infections
Yes 408 (35.6) -
No 524 (45.7) -
Obstetric history
Nulliparous 425 (37.1) -
1 live birth 664 (57.9) -
≥ 2 live births 57 (5.0) -
Regions
North/Beijing 245 (21.4) 197 (35.4)
East/Hangzhou 248 (21.6) 64 (11.5)
Central/Changsha 229 (20.0) 33 (5.9)
Southwest/Chengdu 176 (15.4) 67 (12.0)
South/Guangzhou 248 (21.6) 196 (35.2)
*Underclassmen refers to first- and second-year undergraduate students,
upperclassmen refers to third- and fourth-year undergraduate students.
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Employed women also reported increased intention to
undergo routine gynecologic exam after the intervention
from 601/1146 (52%) to 974/1061 (92%), (p < 0.001).
Attitudes and acceptability towards the HPV vaccine
Willingness to receive HPV vaccination increased signifi-
cantly post-intervention from 881/1146 (77%) to 953/1061
(90%) in employed women and from 405/557 (73%) to
266/325 (82%) in students, (p < 0.01). Female undergradu-
ate students over age 20 were 1.6 times more willing toreceive vaccination (0.9-2.9) than those under age 20.
Knowledge of cervical cancer, concern about contracting
cervical cancer, and approval of widespread usage of the
vaccine were factors that influenced willingness to receive
vaccination (OR 2.4 (1.3-4.8), 2.8 (1.6-5.0), and 4.3 (2.4-7.6),
respectively). 265/1146 (23%) of employed women and
152/557 (27%) of female undergraduate students were un-
willing to receive vaccination for themselves. The most
common reasons against vaccination given by both groups
of participants was concern about vaccine safety (325/
1146 (58%) in women and 459/557 (40%) in students),
concern about vaccine efficacy (331/1146 (29%) in women
and 238/557 (43%) in students), and limited usage of the
vaccine to date (258/1146 (23%) in women and 177/557
(32%) in students). Baseline attitudes and vaccine accept-
ability are shown in Figure 2 and comparison of pre- and
post-interventional vaccine acceptability are shown in
Figure 3.
Post-intervention, willingness of employed women to
vaccinate their children increased from 502/1146 (44%)
to 857/1061 (81%), (χ2 = 261.7, p < 0.001). However,
175/1061 (16%) women were still unwilling to vaccinate
their children after educational instruction due to con-
cerns about vaccine safety (249/1061 (24%)), concerns
about vaccine efficacy (136/1061 (13%)), and belief that
their children are too young to be at risk (233/1061
(22%)). Comparison of pre- and post-educational HPV
vaccine attitudes is shown in Figure 3.
Logistic regression examining the effect of various
sociodemographic predictors and cervical cancer risk on
maternal willingness to vaccinate their children is
presented in Table 2. Women were more likely to be will-
ing to vaccinate their children if they were between the
ages of 36 to 45 (OR = 0.35 (0.18-0.68), p = 0.002) and if
they were concerned about contracting cervical cancer
themselves (OR = 1.8 (1.1-3.2), p = 0.03). Overall, 902/
1703 (53%) of all participants chose the China Center for
Disease Control and 426/1703 (25%) chose women and
children’s hospitals as the ideal location to receive the
HPV vaccine.Discussion
The brief educational intervention in our study effectively
raised HPV and HPV vaccine knowledge in undergraduate
students and employed women, and also increased vaccine
acceptability. Post-intervention, women were twice as
likely to report willingness to vaccinate their children and
correctly identified younger ages as ideal for receiving the
HPV vaccine. This is of particular significance because a
recent study suggests for optimal vaccine compliance, girls
in China should be vaccinated between the ages of 13-15,
prior to concluding their mandatory schooling and be-
coming sexually active [18].
Figure 2 Baseline HPV, cervical cancer, and HPV vaccine knowledge.
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vical cancer in the future, clinical trials across China are
ongoing. An effective HPV education program that ad-
dresses specific knowledge gaps and common questions
among women of different regions, education levels, and
cultures has been demonstrated to increase the success of
large-scale vaccination programs [21]. Studies in the U.S.
have found that educational programs should emphasize
vaccine effectiveness and the high likelihood of HPV infec-
tion, and address barriers to vaccination [14]. A similar
study in Japan found that vaccine safety and cost should
be addressed to increase maternal vaccine acceptability for
their children [28]. Women also reported increased vac-
cine acceptability for themselves and their children after
hearing physician and government endorsements of the
HPV vaccine [25,28].
To our knowledge, the present study represents the first
evaluation of a large-scale HPV educational intervention
in Mainland China. Kwan et al. [26,27] have conducted
similar HPV knowledge and education studies in Hong
Kong, yet no similar educational interventions have been
conducted in Mainland China. A previous study by Zhang
and colleagues [18] examined HPV knowledge alone in
China among the general female population, healthcare
personnel, and government officials. Our results confirm
their findings of low baseline HPV knowledge among
employed women and female undergraduate students. In
addition, our survey of employed women and female
undergraduate students paints a more comprehensivepicture of HPV knowledge in different female population
groups across Mainland China.
The results of our present study indicate that baseline
HPV knowledge is low among employed women and fe-
male undergraduate students in northern, eastern, central,
southern, and southwestern regions of China. Through
our study, we also gained valuable insight into the pre-
ferred methods of obtaining HPV-related information and
social beliefs held among Chinese women. Employed
women and female college students preferred to receive
HPV-related information via school or hospital-based lec-
tures. They also believed that a national organization such
as the Center for Disease Control should be responsible
for providing the vaccine. In addition, vaccine safety, effi-
cacy, and cost remained concerns and barriers to vaccin-
ation. Women had no preference for either the domestic
or foreign HPV vaccine, but believed that the government
should support and partially subsidize the cost. Future
HPV education programs can focus on addressing these
aforementioned issues. Furthermore, over 76% of employed
females believe that getting vaccinated is a societal respon-
sibility that should be shared by both genders. Thus, a
government-sponsored, school-based education program
can effectively disperse safe intercourse practices and HPV
vaccine information to both male and female students.
Strengths of our study include the relatively large popu-
lation sampled across five main geographical regions of
Mainland China. We also targeted employed women and
undergraduate female students, two populations who have
Figure 3 Comparison of pre- and post-interventional HPV-related knowledge.
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previous studies, which found that HPV knowledge and
vaccine acceptability were higher among college-educated
women [18,25].
Limitations of our study include the cross-sectional
design. While our educational intervention significantly
increased post-test HPV knowledge and vaccine accept-
ance, the strength of causality is limited by the absence
of a control group. Also, although our questionnaire was
adapted from previous studies, we did not apply a scale
to assess its validity. Future large-scale studies should
devise a reliability scale to evaluate the questionnaire.
Furthermore, our study was mainly carried out in urban
centers among women with higher education levels thus
due to the potential sampling bias, our findings may not
be generalized to the entire Chinese population. HPV
knowledge and vaccine receptivity have been shown to
vary widely based on region, sociodemographic factors
and education level [14,16]. In 2007, a survey of 400
Uyghur women in Xinjiang found only 5% had heard of
cervical cancer [29]. A more recent study in 2011 on
1005 Han, Uyghur, and Muslim women residing in
Xinjiang found that only 5.2% of Uyghur women and
11.5% of Muslim women knew the association betweenHPV infection and cervical cancer, suggesting that the
findings of our study may not be generalized to different
groups of Chinese women [30]. This highlights the need
for culturally salient HPV and cervical cancer education
especially among Chinese ethnic minority populations.
Furthermore, while HPV and HPV vaccine knowledge
significantly improved immediately following the brief
educational intervention, its lasting impact is unknown.
It is also uncertain whether vaccine acceptability and
positive attitudes towards vaccination would persist and
translate into higher vaccination rates.
Conclusions
Our study demonstrates that incorporation of our educa-
tional initiative into a government sponsored or school
based program may improve willingness to accept HPV
vaccination. The potential implications of our study are
far-reaching during this pivotal time of HPV vaccine
clinical trials in China. It is important to establish the link
between HPV infection and the development of cervical
cancer, and to educate women on the ideal time to vaccin-
ate their children. Studies have shown that maternal atti-
tudes towards vaccination greatly impacts vaccination
rates among children. It is also imperative to dispel
Table 2 Logistic regression analysis for maternal willingness to vaccinate their children
Characteristics of employed women N Willingness to vaccinate their children
N (%) Ajusted OR (95% CI) Walds χ2 P
Age (yrs)
≤25 164 61 (59.2) 1.00
26-35 292 91 (37.1) 1.16 (0.37-3.7) 0.06 0.80
36-45 282 96 (41.2) 0.35 (0.18-0.68) 9.45 0.00
>45 253 99 (51.3) 0.46 (0.25-0.87) 5.76 0.02
Education level
≤High school 408 154 (49.36) 1.00
> High school 703 229 (41.11) 0.93 (0.53-1.6) 0.07 0.79
Occupation
Skilled professionals 821 278 (42.25) 1.00
Manual laborers 132 53 (51.46) 0.52 (0.16-1.8) 1.10 0.29
Others 64 25 (50.00) 1.2 (0.29-4.9) 0.05 0.82
Household registration
Rural 112 39 (50.65) 1.00
Urban 707 241 (43.11) 0.91 (0.29-2.9) 0.02 0.88
History of childbirth
No 524 172 (41.55) 1.00
Yes 408 159 (46.90) 0.98 (0.6-1.6) 0.01 0.94
Number of lifetime sexual partners
1 668 231 (41.77) 1.00
≥2 87 43 (54.43) 2.0 (0.95-4.2) 3.3 0.1
Prior experience with vaccinations outside the EPI (e.g., flu vaccine)
No 810 279 (42.27) 1.0
Yes 266 100 (47.39) 1.0 (0.58-1.7) <0.001 1.0
Fear of developing cervical cancer
No 222 62 (35.23) 1.0
Yes 586 243 (49.90) 1.8 (1.06-3.2) 4.6 0.0
Voluntarily sought out HPV-related information
No 981 344 (42.95) 1.0
Yes 82 39 (55.71) 1.4 (0.64-3.2) 0.8 0.4
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partners need to be vaccinated.
Future directions for research include the develop-
ment of a longitudinal, national HPV education pro-
gram appropriate for school-based curriculum. Due to
our limited participant sampling, our findings may not
be generalized to the entire heterogeneous Chinese fe-
male population. Widespread implementation among
different geographic regions and minority populations
across China would shed light on the long-lasting
impact of HPV education. Also, it is important develop
evaluation and feedback tools to assess the effective-
ness of the program. Lastly, follow-up studies must be
performed to see if increased HPV and HPV vaccineknowledge translates into higher vaccination rates and
vaccine compliance within China.
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